Academic Symposium on Urinary Tumor Immunotherapy was successfully held at the First People's Hospital of Xianyang City

On June 24th, the third phase of the Xixian Urology Summit Forum and the academic seminar of urinary tumor immunotherapy (Xianyang Station) were successfully held at Xianyang City First People's Hospital, which aims to further enhance medical staff in Xi and Xianxian. The understanding of the latest drug treatment of tumors. This meeting invited Yuan Jianlin, the president of the Shaanxi Medical Association Men's Association, director of the All -Army Urology Center, and well -known urology experts in the province. Lu Jian, Dean of the First People's Hospital of Xianyang City, attended the meeting. Essence

Professor Yuan Jianlin, president of the Shaanxi Physician Association, delivered a speech to the conference to express his warm congratulations to the meeting of this meeting. The various achievements of the Department of Urology of the First People's Hospital of Xianyang City are very appreciated and relieved. At the same time, Professor Yuan hopes that the First People's Hospital of Xianyang City will move forward and climb the peak again, and wishes the conference a complete success.

Lu Jian, president of the first hospital of the city, delivered a high degree of affirmation of the discipline development of urology. Thanks for the visit of the physician association and experts. I hope that experts, professors, and colleagues can have the latest progress in sharing and exchanging urinary tumor immunotherapy. Effectively promote the academic development of urological development of Xixian and Xianxian in this field, help the development of urological development of grassroots medical units in Xi'an, Xianyang, and even the provinces, and make positive contributions to promoting the scientific and technological progress of the urinary industry and the development of local health.

At the meeting, Professor Wu Guojun, Dean Wu Guojun, Dean of Xi'an People's Hospital, shared the "Latest Progressive Progress of Urinary Cancer Cancer therapy", showing the latest scientific information of urinary epithelial cancer, especially bladder cancer treatment; the second affiliated to Xi'an Jiaotong University Dr. Zhang Yinbin, Department of Hospital Oncology, shared the "Clinical Management of Adverse Reactions in Immunoier Inspection Point Inhibitors", analyzed the various adverse reactions of bladder tumor immunotherapy, especially for the treatment of severe adverse reactions and long -range management. Dr. Zheng Wanxiang, a Urology of Xijing Hospital affiliated to the University of Air Force Medical University, shared the "Clinical Practice of Urology Tumor Immunotherapy -Case Sharing", and reproduced the latest treatment progress of urinary tumor immunotherapy and the real world experience of drug selection.

The meeting was chaired by Professor Li Zhaomin, Director of the Second Hospital of the First People's Hospital of Xianyang City.

During the meeting, the experts attended a fierce discussion on the immunotherapy of urinary tumors. Experts and professors shared the experience and experience of immunotherapy of urinary tumors without reservation.

Finally, Professor Yuan Jianlin summarized the conference. The content of the academic conference was practical and novel. A series of new choice plans for immunotherapy of urinary tumor was proposed at the meeting. It was the gospel of Xi'an and Xianyang urinary tumor friends. Through the discussion of this academic conference, it laid a good foundation for better immunotherapy for urinary tumors in the future. (Reporter Han Yongguo)

- END -